investigated the T34-A mutant survivin DNA vaccine in combination with radiotherapy in a murine lung carcinoma model, observing enhanced anti-tumor responses with increased apoptosis of tumor cells and decreased microvessel density compared to individual therapies (118). This evidence concerns the gene BIRC5 and neoplasm.